Altogether, identification of TQ-targeted HSPA6 not only reveals a new TQ regulatory mechanism, but also provides a novel candidate target for clinical management and treatment of breast cancer, particularly for TNBC upon TQ. The gene discussed is HSPA6; the disease is breast carcinoma.